FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Telavancin (Vibativ) Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Theravance Biopharma US, Inc. (New 11/23/2016)

Company Contact Information:

Presentation Posting Date Related Information
Vibativ (telavancin) 250mg/vial (NDC 62847-002-01) 11/23/2016 The 750mg/vial presentation continues to be available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English